更正：顺铂与卡铂治疗肺癌患者的血栓栓塞风险
Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
出版信息
PLoS One. 2018 Jan 12;13(1):e0191454. doi: 10.1371/journal.pone.0191454. eCollection 2018.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0189410.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0189410。]
相似文献
1
Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.更正：顺铂与卡铂治疗肺癌患者的血栓栓塞风险
PLoS One. 2018 Jan 12;13(1):e0191454. doi: 10.1371/journal.pone.0191454. eCollection 2018.
2
Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.顺铂与卡铂治疗肺癌患者的血栓栓塞风险。
PLoS One. 2017 Dec 11;12(12):e0189410. doi: 10.1371/journal.pone.0189410. eCollection 2017.
3
Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by 18F-ICMT-11-Positron Emission Tomography.更正：通过18F-ICMT-11-正电子发射断层扫描对肺癌中卡铂治疗疗效的临床前评估。
PLoS One. 2020 Jul 9;15(7):e0235804. doi: 10.1371/journal.pone.0235804. eCollection 2020.
4
Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.更正：通过溶酶体膜通透性调节或自噬抑制来调控溶酶体功能可恢复难治性非小细胞肺癌细胞对顺铂的敏感性。
PLoS One. 2018 May 2;13(5):e0197016. doi: 10.1371/journal.pone.0197016. eCollection 2018.
5
Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.更正：具有干细胞样特征的顺铂耐药非小细胞肺癌细胞系的生成与表征
PLoS One. 2020 May 21;15(5):e0233739. doi: 10.1371/journal.pone.0233739. eCollection 2020.
6
Correction: A Newfound Association between MDC1 Functional Polymorphism and Lung Cancer Risk in Chinese.更正：中国人群中MDC1功能多态性与肺癌风险之间的新发现关联。
PLoS One. 2015 Jan 30;10(1):e0117882. doi: 10.1371/journal.pone.0117882. eCollection 2015.
7
Correction: Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.更正：辅酶Q10加多种维生素治疗可预防大鼠顺铂耳毒性。
PLoS One. 2017 Sep 21;12(9):e0185525. doi: 10.1371/journal.pone.0185525. eCollection 2017.
8
Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.更正：非维生素K拮抗剂口服抗凝药阿哌沙班、达比加群和利伐沙班在静脉血栓栓塞症长期治疗和预防中的比较：系统评价和网状Meta分析。
PLoS One. 2016 Sep 15;11(9):e0163386. doi: 10.1371/journal.pone.0163386. eCollection 2016.
9
Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.更正：非小细胞肺癌白种人患者对癌睾丸抗原XAGE-1b的免疫反应
PLoS One. 2016 Jul 28;11(7):e0160538. doi: 10.1371/journal.pone.0160538. eCollection 2016.
10
Correction: Cisplatin-Induced Non-Oliguric Acute Kidney Injury in a Pediatric Experimental Animal Model in Piglets.更正：仔猪儿科实验动物模型中顺铂诱导的非少尿型急性肾损伤
PLoS One. 2018 Nov 9;13(11):e0207547. doi: 10.1371/journal.pone.0207547. eCollection 2018.
引用本文的文献
1
MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer.miR-514 通过靶向 ABC 转运子家族抑制卵巢癌细胞增殖并增加化疗耐药性
Mol Genet Genomics. 2018 Oct;293(5):1159-1167. doi: 10.1007/s00438-018-1447-0. Epub 2018 May 11.
本文引用的文献
1
Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.顺铂与卡铂治疗肺癌患者的血栓栓塞风险。
PLoS One. 2017 Dec 11;12(12):e0189410. doi: 10.1371/journal.pone.0189410. eCollection 2017.
Zotero 插件